EDN1 and systemic sclerosis: Endothelin-1 (ET-1) serves as a key mediator of vascular hypertrophy, cellular proliferation, inflammation, and fibrosis, and is overexpressed in the plasma of patients with systemic sclerosis, particularly those with DUs and/or pulmonary arterial hypertension (PAH) [5,6].